1. Home
  2. BSY vs RDY Comparison

BSY vs RDY Comparison

Compare BSY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bentley Systems Incorporated Class B

BSY

Bentley Systems Incorporated Class B

N/A

Current Price

$40.30

Market Cap

11.8B

Sector

Technology

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$14.36

Market Cap

11.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSY
RDY
Founded
1984
1984
Country
United States
India
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
11.6B
IPO Year
2002
2001

Fundamental Metrics

Financial Performance
Metric
BSY
RDY
Price
$40.30
$14.36
Analyst Decision
Buy
Strong Buy
Analyst Count
12
1
Target Price
$49.08
$16.90
AVG Volume (30 Days)
3.6M
1.5M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
0.70%
0.50%
EPS Growth
18.06
N/A
EPS
0.85
N/A
Revenue
$734,849,000.00
N/A
Revenue This Year
$13.47
$7.50
Revenue Next Year
$10.39
$2.96
P/E Ratio
$46.86
$18.67
Revenue Growth
6.24
N/A
52 Week Low
$30.97
$12.26
52 Week High
$59.25
$16.17

Technical Indicators

Market Signals
Indicator
BSY
RDY
Relative Strength Index (RSI) 68.27 54.90
Support Level $39.84 $14.20
Resistance Level $43.37 $14.66
Average True Range (ATR) 1.35 0.26
MACD 0.86 -0.04
Stochastic Oscillator 99.22 45.68

Price Performance

Historical Comparison
BSY
RDY

About BSY Bentley Systems Incorporated Class B

Bentley Systems is a software vendor that caters to civil engineers, constructors, and geospatial professionals by enabling design, simulation, and data management of infrastructure assets such as roads and bridges. While Bentley is smaller than many other design software companies, it is a market leader across a handful of specialty areas, including public works, electricity grids, and transit.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: